⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Sapphire Equity Long-Short SIF - IDCW - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Sapphire SIF | HDFC MF |
| Category | Equity - Long-Short Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹957.98 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Arihant Jain | Nikhil Mathur |
| Inception | 29 Apr 2026 | 04 Oct 2023 |
| Returns | ||
| 1Y | — | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | -4.20% | 29.15% |
| Risk | ||
| 8.76 | 14.07 | |
| 0.84 | 0.59 | |
| -1.43 | 1.59 | |
| -4.66 | 21.67 | |
| -2.04 | 3.48 | |
| -5.91% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.34% | 1.03% |
| Exit Load | 1% on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹10,000 | ₹100 |
| Min Lumpsum | ₹10,00,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Sapphire SIF98%
HDFC MF98%
1.5%Only 1.5% of holdings by weight are common between Sapphire SIF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingSapphire SIFHDFC MF
Sun Pharmaceutical Industries Ltd.1.51%8.28%
Category context: Equity vs Equity. Open the full Screener →